Japan Approves First Over-The-Counter Emergency Contraceptive Pill: A Major Breakthrough for Women's Healthcare Access

Japan has made a significant healthcare advancement by approving the first over-the-counter emergency contraceptive pill through ASKA Pharmaceutical's Norlevo. This landmark decision eliminates prescription requirements that previously hindered access, especially for vulnerable groups. While pharmacist supervision is still required, the medication will be available without age restrictions or parental consent, bringing Japan in line with over 90 countries that already provide non-prescription emergency contraception.

Japan Approves Sale Of First Over-The-Counter Emergency Contraceptive Pill

Japan has officially granted regulatory approval for the country's first over-the-counter emergency contraceptive pill, as announced by manufacturer ASKA Pharmaceutical on Monday.

This landmark decision marks the first time that Japan, traditionally considered socially conservative, has permitted access to "morning-after" medication without requiring a doctor's prescription.

For years, advocacy groups have criticized Japan's restrictive approach that forced women to obtain a prescription and visit a clinic or pharmacy to access emergency contraception. These barriers have particularly affected vulnerable groups such as sexual assault survivors and adolescent girls.

ASKA Pharmaceutical confirmed in their press release that they have successfully "obtained manufacturing and marketing approval" for their emergency contraceptive product called Norlevo.

According to the Mainichi Shimbun newspaper, the medication will be available without age restrictions and will not require parental consent for purchase.

However, the pill will carry a designation of "medicine requiring guidance," meaning women must take it in the presence of a pharmacist rather than at home.

Emergency contraceptive pills are designed to prevent pregnancy when taken within 72 hours after unprotected intercourse, though their effectiveness diminishes as time passes.

The path to this approval began in 2017 when a health ministry panel first initiated discussions about non-prescription access to emergency contraception.

This decision follows a limited pilot program launched in 2023, which involved only 145 pharmacies across Japan—less than 0.2 percent of all pharmacies in the country.

During the trial period, the emergency contraceptive was priced between 7,000 and 9,000 yen (approximately $47 to $60).

Over 90 countries worldwide already provide emergency contraception without prescription requirements.

The World Health Organization advocates that emergency contraception "should be routinely included within all national family planning programmes" as part of comprehensive reproductive healthcare.

Source: https://www.ndtv.com/world-news/japan-approves-sale-of-first-over-the-counter-emergency-contraceptive-pill-9487464